Sherar Michael, Maley Oonagh
President and CEO at Cancer Care Ontario.
Director, Corporate Strategy, Planning & Performance at Cancer Care Ontario.
Healthc Q. 2015;17 Spec No:52-6. doi: 10.12927/hcq.2014.24011.
Since 2004, Cancer Care Ontario (CCO) has played a leadership role in linking funding to quality of care, and in using evidence and administrative and clinical data to drive performance and quality improvement. This article describes how CCO has used its cancer and renal health system strategies to establish an environment of continuous health system improvement. The article also describes how CCO's Corporate Strategy is driving organizational improvement: evolving CCO's capacity and capability to drive quality and value across healthcare settings, and its ability to advance broader health system transformation in support of cancer and renal patients.
自2004年以来,安大略癌症护理组织(CCO)在将资金与护理质量挂钩,以及利用证据、行政和临床数据推动绩效和质量改进方面发挥了领导作用。本文描述了CCO如何利用其癌症和肾脏健康系统战略来营造持续改进健康系统的环境。本文还描述了CCO的企业战略如何推动组织改进:提升CCO在各类医疗环境中推动质量和价值的能力,以及推进更广泛的健康系统转型以支持癌症和肾脏疾病患者的能力。